标题 |
A randomized, double-blind, placebo-controlled, multicenter phase III trial of everolimus + octeotride LAR vs placebo + octeotride LAR in patients with advanced neuroendocrine tumors(NET) (RADIANT-2)
依维莫司+octeotride LAR与安慰剂+octeotride LAR治疗晚期神经内分泌肿瘤(NET)患者的随机、双盲、安慰剂对照、多中心III期试验(RADIANT-2)
|
网址 |
求助人暂未提供
|
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
其它 | Pavel M, Hainsworth J, Baudin E, Peeters M, Hoersch D, Anthony L, et al. A randomized, double-blind, placebo-controlled, multicenter phase III trial of everolimus + octeotride LAR vs placebo+ octeotride LAR in patients with advanced neuroendocrine tumors(NET) (RADIANT-2). Ann Oncol 2010;21(Suppl 8):LBA8. |
求助人 | |
下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |